Lactoferrin decreases LPS-induced mitochondrial dysfunction in cultured cells and in animal endotoxemia model

Marian L. Kruzel, Jeffrey K. Actor, Zsolt Radak, Attila Bacsi, Alfredo Saavedra-Molina, Istvan Boldogh

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

Lactoferrin is a non-heme iron-binding glycoprotein, produced by mucosal epithelial cells and granulocytes in most mammalian species. It is involved in regulation of immune responses, possesses anti-oxidant, anti-carcinogenic, anti-inflammatory properties, and provides protection against various microbial infections. In addition, lactoferrin has been implicated in protection against the development of insult-induced systemic inflammatory response syndrome (SIRS) and its progression into septic conditions in vivo. Here we show a potential mechanism by which lactoferrin lessens oxidative insult at the cellular and tissue levels after lipopolysaccharide (LPS) exposure. Lactoferrin pretreatment of cells decreased LPS-mediated oxidative insults in a dose-dependent manner. Lipopolysaccharideinduced oxidative burst was found to be of mitochondrial origin, and release of reactive oxygen species (ROS) was localized to the respiratory complex III. Importantly, lactoferrin nearly abolished LPS-induced increases in mitochondrial ROS generation and the accumulation of oxidative damage in the DNA. In vivo, pretreatment of experimental animals with lactoferrin significantly (P < 0.05) lowered LPS-induced mitochondrial dysfunction as shown by both decreased release of H2O2 and DNA damage in the mitochondria. In contrast, deferoxamine, an iron chelating compound, provided only partial protection in LPS-treated animals. Together, these data suggest that lactoferrin protects against oxidative insult at the mitochondrial level, and indicate a potential utility of lactoferrin in prevention and treatment of SIRS.

Original languageEnglish
Pages (from-to)67-79
Number of pages13
JournalInnate Immunity
Volume16
Issue number2
DOIs
Publication statusPublished - 2010 Apr 1
Externally publishedYes

Fingerprint

Lactoferrin
Endotoxemia
Lipopolysaccharides
Cultured Cells
Animal Models
Systemic Inflammatory Response Syndrome
DNA Damage
Reactive Oxygen Species
Iron Compounds
Deferoxamine
Respiratory Burst
Electron Transport Complex III
Granulocytes
Oxidants
Glycoproteins
Mitochondria
Anti-Inflammatory Agents
Iron
Epithelial Cells
Infection

Keywords

  • DNA damage
  • Lactoferrin
  • Mitochondria
  • Oxidative stress

ASJC Scopus subject areas

  • Cell Biology
  • Molecular Biology
  • Immunology
  • Microbiology
  • Infectious Diseases

Cite this

Kruzel, M. L., Actor, J. K., Radak, Z., Bacsi, A., Saavedra-Molina, A., & Boldogh, I. (2010). Lactoferrin decreases LPS-induced mitochondrial dysfunction in cultured cells and in animal endotoxemia model. Innate Immunity, 16(2), 67-79. https://doi.org/10.1177/1753425909105317

Lactoferrin decreases LPS-induced mitochondrial dysfunction in cultured cells and in animal endotoxemia model. / Kruzel, Marian L.; Actor, Jeffrey K.; Radak, Zsolt; Bacsi, Attila; Saavedra-Molina, Alfredo; Boldogh, Istvan.

In: Innate Immunity, Vol. 16, No. 2, 01.04.2010, p. 67-79.

Research output: Contribution to journalArticle

Kruzel, ML, Actor, JK, Radak, Z, Bacsi, A, Saavedra-Molina, A & Boldogh, I 2010, 'Lactoferrin decreases LPS-induced mitochondrial dysfunction in cultured cells and in animal endotoxemia model', Innate Immunity, vol. 16, no. 2, pp. 67-79. https://doi.org/10.1177/1753425909105317
Kruzel, Marian L. ; Actor, Jeffrey K. ; Radak, Zsolt ; Bacsi, Attila ; Saavedra-Molina, Alfredo ; Boldogh, Istvan. / Lactoferrin decreases LPS-induced mitochondrial dysfunction in cultured cells and in animal endotoxemia model. In: Innate Immunity. 2010 ; Vol. 16, No. 2. pp. 67-79.
@article{0e31031a2fc24879b6cf7a3846f156b2,
title = "Lactoferrin decreases LPS-induced mitochondrial dysfunction in cultured cells and in animal endotoxemia model",
abstract = "Lactoferrin is a non-heme iron-binding glycoprotein, produced by mucosal epithelial cells and granulocytes in most mammalian species. It is involved in regulation of immune responses, possesses anti-oxidant, anti-carcinogenic, anti-inflammatory properties, and provides protection against various microbial infections. In addition, lactoferrin has been implicated in protection against the development of insult-induced systemic inflammatory response syndrome (SIRS) and its progression into septic conditions in vivo. Here we show a potential mechanism by which lactoferrin lessens oxidative insult at the cellular and tissue levels after lipopolysaccharide (LPS) exposure. Lactoferrin pretreatment of cells decreased LPS-mediated oxidative insults in a dose-dependent manner. Lipopolysaccharideinduced oxidative burst was found to be of mitochondrial origin, and release of reactive oxygen species (ROS) was localized to the respiratory complex III. Importantly, lactoferrin nearly abolished LPS-induced increases in mitochondrial ROS generation and the accumulation of oxidative damage in the DNA. In vivo, pretreatment of experimental animals with lactoferrin significantly (P < 0.05) lowered LPS-induced mitochondrial dysfunction as shown by both decreased release of H2O2 and DNA damage in the mitochondria. In contrast, deferoxamine, an iron chelating compound, provided only partial protection in LPS-treated animals. Together, these data suggest that lactoferrin protects against oxidative insult at the mitochondrial level, and indicate a potential utility of lactoferrin in prevention and treatment of SIRS.",
keywords = "DNA damage, Lactoferrin, Mitochondria, Oxidative stress",
author = "Kruzel, {Marian L.} and Actor, {Jeffrey K.} and Zsolt Radak and Attila Bacsi and Alfredo Saavedra-Molina and Istvan Boldogh",
year = "2010",
month = "4",
day = "1",
doi = "10.1177/1753425909105317",
language = "English",
volume = "16",
pages = "67--79",
journal = "Innate Immunity",
issn = "1753-4259",
publisher = "SAGE Publications Ltd",
number = "2",

}

TY - JOUR

T1 - Lactoferrin decreases LPS-induced mitochondrial dysfunction in cultured cells and in animal endotoxemia model

AU - Kruzel, Marian L.

AU - Actor, Jeffrey K.

AU - Radak, Zsolt

AU - Bacsi, Attila

AU - Saavedra-Molina, Alfredo

AU - Boldogh, Istvan

PY - 2010/4/1

Y1 - 2010/4/1

N2 - Lactoferrin is a non-heme iron-binding glycoprotein, produced by mucosal epithelial cells and granulocytes in most mammalian species. It is involved in regulation of immune responses, possesses anti-oxidant, anti-carcinogenic, anti-inflammatory properties, and provides protection against various microbial infections. In addition, lactoferrin has been implicated in protection against the development of insult-induced systemic inflammatory response syndrome (SIRS) and its progression into septic conditions in vivo. Here we show a potential mechanism by which lactoferrin lessens oxidative insult at the cellular and tissue levels after lipopolysaccharide (LPS) exposure. Lactoferrin pretreatment of cells decreased LPS-mediated oxidative insults in a dose-dependent manner. Lipopolysaccharideinduced oxidative burst was found to be of mitochondrial origin, and release of reactive oxygen species (ROS) was localized to the respiratory complex III. Importantly, lactoferrin nearly abolished LPS-induced increases in mitochondrial ROS generation and the accumulation of oxidative damage in the DNA. In vivo, pretreatment of experimental animals with lactoferrin significantly (P < 0.05) lowered LPS-induced mitochondrial dysfunction as shown by both decreased release of H2O2 and DNA damage in the mitochondria. In contrast, deferoxamine, an iron chelating compound, provided only partial protection in LPS-treated animals. Together, these data suggest that lactoferrin protects against oxidative insult at the mitochondrial level, and indicate a potential utility of lactoferrin in prevention and treatment of SIRS.

AB - Lactoferrin is a non-heme iron-binding glycoprotein, produced by mucosal epithelial cells and granulocytes in most mammalian species. It is involved in regulation of immune responses, possesses anti-oxidant, anti-carcinogenic, anti-inflammatory properties, and provides protection against various microbial infections. In addition, lactoferrin has been implicated in protection against the development of insult-induced systemic inflammatory response syndrome (SIRS) and its progression into septic conditions in vivo. Here we show a potential mechanism by which lactoferrin lessens oxidative insult at the cellular and tissue levels after lipopolysaccharide (LPS) exposure. Lactoferrin pretreatment of cells decreased LPS-mediated oxidative insults in a dose-dependent manner. Lipopolysaccharideinduced oxidative burst was found to be of mitochondrial origin, and release of reactive oxygen species (ROS) was localized to the respiratory complex III. Importantly, lactoferrin nearly abolished LPS-induced increases in mitochondrial ROS generation and the accumulation of oxidative damage in the DNA. In vivo, pretreatment of experimental animals with lactoferrin significantly (P < 0.05) lowered LPS-induced mitochondrial dysfunction as shown by both decreased release of H2O2 and DNA damage in the mitochondria. In contrast, deferoxamine, an iron chelating compound, provided only partial protection in LPS-treated animals. Together, these data suggest that lactoferrin protects against oxidative insult at the mitochondrial level, and indicate a potential utility of lactoferrin in prevention and treatment of SIRS.

KW - DNA damage

KW - Lactoferrin

KW - Mitochondria

KW - Oxidative stress

UR - http://www.scopus.com/inward/record.url?scp=77952395053&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77952395053&partnerID=8YFLogxK

U2 - 10.1177/1753425909105317

DO - 10.1177/1753425909105317

M3 - Article

C2 - 19723832

AN - SCOPUS:77952395053

VL - 16

SP - 67

EP - 79

JO - Innate Immunity

JF - Innate Immunity

SN - 1753-4259

IS - 2

ER -